Genetics of drug transformation
- 30 April 1986
- journal article
- review article
- Published by Elsevier in Clinical Biochemistry
- Vol. 19 (2), 76-82
- https://doi.org/10.1016/s0009-9120(86)80052-2
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- The genetic defect of mephenytoin hydroxylationXenobiotica, 1986
- Oxidation phenotype and the metabolism and action of beta-blockersKlinische Wochenschrift, 1985
- High affinity of quinidine for a stereoselective microsomal binding site as determined by a radioreceptor assayCellular and Molecular Life Sciences, 1984
- Genetically determined debrisoquine oxidation capacity in bladder cancerCarcinogenesis: Integrative Cancer Research, 1984
- Pharmacogenetic Perspectives: Genes, Drugs and DiseaseHepatology, 1984
- A human cytochrome P-450 characterized by inhibition studies as the sparteine–debrisoquine monooxygenaseCanadian Journal of Physiology and Pharmacology, 1984
- Bufuralol metabolism in human liver: a sensitive probe for the debrisoquine‐type polymorphism of drug oxidationEuropean Journal of Clinical Investigation, 1984
- Human cytochromes P-450Xenobiotica, 1984
- The fate of orally administered [4-l4C]phenytoin in two healthy male volunteersCanadian Journal of Physiology and Pharmacology, 1983
- A Population and Familial Study of the Defective Alicyclic Hydroxylation of Debrisoquine among EgyptiansXenobiotica, 1979